Curative Biotechnology Inc (CUBT)

[MarkDaShark]

Board members have to declare their stock moves before hand, and considering it moved up with 80 million volume in the first NIH grant, who knows how the market will react to it. Yes technically it would readjust the market cap and stuff and that would indicate it going down, but why would they do that so early into a company who is planning to go to trial early and mid next year? Even if you think this is a pump and dump, it's still going to be pumping until December, and by then we will have news about university partners who are conducting the trial and more clear news about funding.